Human papillomavirus genotypes and the p53 codon 72 polymorphism in cervical cancer of Northeastern Thailand

Microbiology and Immunology

Volumn 49, Issue 5, 2005, Pages 417-421

  Settheetham Ishida, Wannapa ^a   Kanjanavirojkul, Nipa ^a   Kularbkaew, Churairat ^a   Ishida, Takafumi ^b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cervical cancer; HPV sub strains; Northeast Thailand; p53 codon 72 polymorphism

Indexed keywords

PROTEIN P53;

ARTICLE; CANCER RISK; CODON; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MAJOR CLINICAL STUDY; PREVALENCE; PROTEIN POLYMORPHISM; SQUAMOUS CELL CARCINOMA; THAILAND; UTERINE CERVIX CANCER; VIRUS CARRIER; VIRUS INFECTION; WART VIRUS;

CANCER VIRUS; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPES;

EID: 20444399153     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2005.tb03745.x     Document Type: Article

References (26)

1. Andersson, S., Rylander, E., Strand, A., Sallstrom, J., and Wilander, E. 2001. The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas. Br. J. Cancer 85: 1153-1156.
2. Cancer Unit 2003. Khon Kaen University Tumor Registry 2002: statistical report, Thailand.
3. de Villiers, E.M. 1994. Human pathogenic papillomavirus types: an update. Curr. Top. Microbiol. Immunol. 186: 1-12.
4. Ekalaksananan, T., Pientong, C., Kotimanusvanij, D., Kongyingyoes, B., Sriamporn, S., and Jintakanon, D. 2001. The relationship of human papillomavirus (HPV) detection to Pap smear classification of cervical-scraped cells in asymptomatic women in northeast Thailand. J. Obstet. Gynaecol. Res. 27: 117-124.
5. Heiland, A., Langerod, A., Johnsen, H., Olsen, A.O., Skovlund, E., and Borresen-Dale, A.L. 1998. p53 polymorphism and risk of cervical cancer. Nature 396: 530-531.
6. Iwasawa, A., Nieminen, P., Lehtinen, M., and Paavonen, J. 1996. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction. Cancer 77: 2275-2279.
7. Kim, J.W., Roh, J.W., Park, N.H., Song, Y.S., Kang, S.B., and Lee, H.P. 2001. Polymorphism of TP53 codon 72 and the risk of cervical cancer among Korean women. Am. J. Obstet. Gynecol. 184: 55-58.
8. Kjaer, S.K., and Brinton, L. 1993. Adenocarcinomas of the uterine cervix: the epidemiology of an increasing problem. Epidemiol. Rev. 15: 486-498.
9. Klug, S.J., Wilmotte, R., Santos, S., Almonte, M., Herrero, R., Guerrero, I., Caceres, E., Peixoto-Guimaraes, D., Lenoir, G., Hainaut, P., Walboomers, J.M., and Munoz, N. 2001. TP 53 polymorphism, HPV infection, and risk of cervical cancer. Cancer Epidemiol. Biomarkers Prev. 10: 1009-1012.
10. Lertworapreecha, M., Bhattarakosol, P., and Niruthisard, S. 1998. Detection and typing of human papillomavirus in cervical intraepithelial neoplasia grade III in Thai women. Southeast Asian J. Trop. Med. Public Health 29: 507-511.
11. Limpaiboon, T., Pooart, J., Bhattarakosol, P., Niruthisard, S., Chantratita, W., and Lulitanond, V. 2000. p53 status and human papillomavirus infection in Thai women cervical carcinoma. Southeast Asian J. Trop. Med. Public Health 31: 66-71.
12. Makni, H., Franco, E.L., Kaiano, J., Villa, L.L., Labrecque, S., Dudley, R., Storey, A., and Matlashewski, G. 2000. P53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: effect of inter-laboratory variation. Int. J. Cancer 87: 528-533.
13. Minaguchi, T., Kanamori, Y., Matsushima, M., Yoshikawa, H., Taketani, Y., and Nakamura, Y. 1998. No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection. Cancer Res. 58: 4585-4586.
14. Monoz, N., Bosch, F.X., de Sanjose, S., Tafur, L., Izarzugaza, I., Gili, M., Viladiu, P., Navarro, C., Martos, C., Ascunce, N., Gonzalez, L.C., Kaldor, M., Gerrero, E., Lorincz, A., Santamaria, M., de Ruiz, P.A., Arisizabal, N., and Shah, K.V. 1992. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int. J. Cancer 52: 743-749.
15. Pegoraro, R., Moodley, J., Nailker, S., Lanning, P., and Rom, L. 2000. The p53 codon 72 polymorphism in black South African women and the risk of cervical cancer. Br. J. Obstet. Gynaecol. 107: 1164-1165.
16. Rosenthal, A.N., Ryan, A., Al-Jehani, R.M., Storey, A., Harwood, C.A., and Jacobs, I.J. 1998. p53 codon 72 polymorphism and risk of cervical cancer in UK. Lancet 352: 871-872.
17. Scheffner, M., Werness, B.A., Huibregtse, J.M., Levine, A.J., and Howley, P.M. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136.
18. Schiffman, M., and Castle, P.E. 2003. Human papillomavirus: epidemiology and public health. Arch. Pathol. Lab. Med. 127: 930-934.
19. Settheetham-Ishida, W., Singto, U., Yuenyao, P., Kanjanavirojkul, N., Tassaneeyakul, W., and Ishida, T. 2004. Contribution of epigenetic risk factors but not p53 codon 72 polymorphism to the development of cervical cancer in Northeastern Thailand. Cancer Lett. 210: 205-211.
20. Storey, A., Thomas, M., Kalita, A., Harwood, C., Gardiol, D., Mantovani, F., Breuer, J., Leigh, I.M., Matlashewski, G., and Banks, L. 1998. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393: 229-234.
21. Sukvirach, S., Smith, J.S., Tunsakul, S., Munoz, N., Kesararat, V., Opasatian, O., Chichareon, S., Kaenploy, V., Ashley, R., Meijer, C.J., Snijders, P.J., Coursaget, P., Franceschi, S., and Herrero, R. 2003. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. J. Infect. Dis. 187: 1246-1256.
22. Thomas, D.B., Ray, R.M., Koetsawang, A., Kiviat, N., Kuypers, J., Qin, Q., Ashley, R.L., and Koetsawang, S. 2001. Human papillomaviruses and cervical cancer in Bangkok. I. Risk factors for invasive cervical carcinomas with human papillomavirus types 16 and 18 DNA. Am. J. Epidemiol. 153: 723-731.
23. Vatanasapt, V., Sriamporn, S., Kams-aard, S., Suwanrungruang, K., Pengsaa, P., Charoensiri, D.J., Chaiyakum, J., and Pesee, M. 1998. Cancer survival in Khon Kaen, Thailand, p. 123-134. In Sankaranarayanan, R., Black, R.J., and Parkin, D.M. (eds), Cancer survival in developing countries, IARC Scientific Publication No. 145, WHO International Agency for Research on Cancer, Lyon.
24. Yang, Y.C., Chang, C.L., and Chen, M.L. 2001. Effect of p53 polymorphism on the susceptibility of cervical cancer. Gynecol. Obstet. Invest. 51: 197-201.
25. Zehbe, I., Voglino, G., Wilander, E., Genta, F., and Tommasino, M. 1999. Codon 72 polymorphism of p53 and its association with cervical cancer. Lancet 354: 218-219.
26. zur Hausen, H. 1991. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184: 9-13.